Hadi Kalantar

Hadi Kalantar

Auto-generated profile, based on publicly available information

Hadi Kalantar

Toxicology Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2020 in Drug Design, Development and Therapy
Verified
Journal Article
Open access
PDF file
MRMozhdeh Roghani
Mozhdeh Roghani
HKHeibatullah Kalantari
Heibatullah Kalantari
MKMohammad Javad Khodayar
Mohammad Javad Khodayar
LKLayasadat Khorsandi
Layasadat Khorsandi
MKMojtaba Kalantar
Mojtaba Kalantar
HKHadi Kalantar
Hadi Kalantar
Introduction: In multiple studies, involvement of oxidative stress in the pathogenesis of methotrexate (MTX)-mediated liver damage has been confirmed. Use of many drugs has been examined experimentally in order to prevent or diminish oxidative stress. However, no study has yet examined the effects of ferulic acid (FA) on MTX-induced liver damage. This study aimed at evaluating the effects of FA on protection against liver damage induced by MTX in mice. Materials and Methods: In this the mice were divided into five groups in a random manner: I) control; II) MTX (20 mg/kg); III and IV) FA (50 and 100 mg/kg) + MTX; and V) FA (100 mg/kg), and we measured serum factors, oxidative stress and inflammatory factors. Results: In the MTX group, accumulation of inflammatory cells, accumulation of red blood cell (RBC), and nuclear pyknosis (NP) were detected in the liver. In line with the histological data, the levels of nitric oxide (NO), malondialdehyde (MDA), interleukin-6 (IL-6), and tumor necrosis factor-α increased (TNF-α), whereas the reduced glutathione (GSH), catalase (CAT), total antioxidant capacity (TAC), superoxide dismutase (SOD), and glutathione peroxidase (GPx) content reduced in the MTX group. However, FA ameliorated these hazardous effects in the antioxidant and anti-inflammatory systems in MTX-treated groups. Conclusion: Based on our findings, oxidative stress impairment and MTX-induced liver damage were ameliorated following FA pretreatment at both histological and biochemical levels. Therefore, FA can be effectively used in abrogation of MTX-induced toxicity.

15 October 2020 in Naunyn-Schmiedeberg's Archives of Pharmacology
Verified
Journal Article
Closed access
PDF file
MGMehdi Goudarzi
Mehdi Goudarzi
MKMojtaba Kalantar
Mojtaba Kalantar
ESElahe Sadeghi
Elahe Sadeghi
MKMojtaba Haghi Karamallah
Mojtaba Haghi Karamallah
HKHadi Kalantar
Hadi Kalantar

1 August 2019 in Pharmacological Reports
Verified
Journal Article
Closed access
MKMojtaba Kalantar
Mojtaba Kalantar
HKHeibatullah Kalantari
Heibatullah Kalantari
MGMehdi Goudarzi
Mehdi Goudarzi
LKLayasadat Khorsandi
Layasadat Khorsandi
SBSamira Bakhit
Samira Bakhit
HKHadi Kalantar
Hadi Kalantar

7 February 2020 in Environmental Science and Pollution Research
Verified
Journal Article
Closed access
PDF file
MGMehdi Goudarzi
Mehdi Goudarzi
MKMojtaba Haghi Karamallah
Mojtaba Haghi Karamallah
AMAlireza Malayeri
Alireza Malayeri
MKMojtaba Kalantar
Mojtaba Kalantar
EMEsrafil Mansouri
Esrafil Mansouri
HKHadi Kalantar
Hadi Kalantar

22 November 2021 in Human & Experimental Toxicology
Verified
Journal Article
Closed access
PDF file
Reza AzadnasabReza Azadnasab
Reza Azadnasab
HKHadi Kalantar
Hadi Kalantar
LKLayasadat Khorsandi
Layasadat Khorsandi
HKHeibatullah Kalantari
Heibatullah Kalantari
MKMohammad Javad Khodayar
Mohammad Javad Khodayar
Background: Due to the fact that methotrexate is widely used both as an immunosuppressive drug and as a chemotherapy agent, many studies are needed to reduce the side effects of this drug on non-target organs. Purpose: This study was designed to investigate the effects of epicatechin (Epi) on MTX (methotrexate)-induced hepatotoxicity in mice. Research Design: After 1 week for adaptation, we randomly divided 42 male Naval Medical Research Institute mice into six groups: (I) control; (II) Epi (100 mg/kg, po); (III) MTX (20 mg/kg, i.p.) on the fifth day; and (IV, V, and VI) Epi (25, 50, and 100 mg/kg, po) + MTX (20 mg/kg, i.p.) on the fifth day. At day 10, the mice were sacrificed and serum factors, oxidative stress markers, and inflammatory cytokines were measured. Results: MTX increased activity level of serum enzymes (alanine aminotransferase and aspartate aminotransferase), lipid peroxidation marker (malondialdehyde), and inflammatory factors including interleukin-1 beta, tumor necrosis factor-alpha, and nitric oxide. Furthermore, MTX decreased glutathione level and activity level of catalase, superoxide dismutase, and glutathione peroxidase. Epi was able to reduce the destructive effects of oxidative/antioxidant system imbalance and inflammatory reactions and also histopathological damage in MTX intoxicated mice. Epi pretreatment reduced liver dysfunction by improving the antioxidant defense system, anti-inflammatory effects, and alleviation of histopathological damage in MTX hepatotoxicity. Conclusions: Accordingly, Epi can be used as a therapeutic agent in hepatotoxicity associated with MTX chemotherapy.

20 December 2021 in BMC Complementary Medicine and Therapies
Verified
Journal Article
Open access
PDF file
ESEhsan Shabani
Ehsan Shabani
HKHeibatullah Kalantari
Heibatullah Kalantari
MKMojtaba Kalantar
Mojtaba Kalantar
MGMehdi Goudarzi
Mehdi Goudarzi
EMEsrafil Mansouri
Esrafil Mansouri
HKHadi Kalantar
Hadi Kalantar
Introduction: Benign prostatic hyperplasia (BPH) is a major urologic problem that mostly develops in older males. Oxidative stress and inflammation influence the occurrence of BPH. Berberine (BBR) is a natural ingredient that has antioxidant and anti-inflammatory properties. The current research aims at examining the effects of BBR on testosterone-stimulated BPH in rats.Methods: Animals were randomly categorized to six groups. In the control group, normal saline and olive oil were injected as the vehicle. BPH group: received testosterone (3 mg/kg, subcutaneous, 28 days), BPH + BBR groups; received BBR (25 and 50 mg/kg, p.o, 28 days), BPH + finasteride groups: received finasteride (1 mg/kg, p.o, 28 days), BBR (50 mg/kg, p.o, alone) was administered for subjects in the BBR group. On the 29th day, after anesthesia, cervical dislocation was used to kill the subjects. Serum concentration of testosterone and dihydrotestosterone was measured and prostate tissues were excised and used for biochemical, inflammation, and histological analysis.Results: BBR prevented increased serum concentrations of testosterone and dihydrotestosterone. BBR considerably reduced BPH-stimulated oxidative stress and inflammation through preventing the rise in lipid peroxidation and nitrite concentration and declined the accumulations of pro-inflammatory cytokines (e.g. interleukin 1β and tumor necrosis factor α) and declining the depletion rate of GSH and the function of catalase and superoxide dismutase. Histopathological investigations reported that administration of BBR could suppress testosterone-stimulated BPH.Conclusion: This study demonstrated that BBR could significantly prevent the development of BPH in rats.